Personalized Therapy Biosimulation Market Growth Trends by Manufacturers, Regions Forecast to 2028

Market Size – USD 1,061.7 Million in 2020, Market Growth – at a CAGR of 14.6%, Market Trends –Increasing focus on developing AI-based biosimulation platforms




The latest research report serves as a perfect example of the precise analysis of the global AI-based clinical trials solution provider market . It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide Personalized Therapy Biosimulation Market industry. The globally-disrupting incidence has impacted nearly every aspect of this business domain. However, the latest study expounds on the present market scenario and forecasts the pandemic’s aftermath, with respect to this industry


The global Personalized Therapy Biosimulation Market size reached USD 1.24 Billion in 2020 and is expected to register a revenue CAGR of 21.5% during the forecast period, according to latest analysis by Emergen Research. Increasing adoption of Artificial Intelligence (AI)-enabled digital technology is a key factor driving global Personalized Therapy Biosimulation Market revenue growth. Increasing use of AI-enabled digital health technologies coupled with patient support platforms is expected to improve patient engagement and retention throughout study duration as well as after study termination, which is expected to propel revenue growth of the global AI-based clinical trial solution provider market.


To get access to the complete report @


Covid 19 impact analysis:


The report contains updated information about the ongoing COVID-19 pandemic and acts as an accurate analysis of the COVID-19 impact on the Personalized Therapy Biosimulation Market . The report draws attention to the COVID-19 impact on the market and its crucial segments. As per the report, the current pandemic is one of the major contributing elements for the potential decline of the market in the coming years. The business sector has been drastically affected by the pandemic, which has adversely altered the market dynamics and demand trends. Financial difficulties brought by the pandemic have delayed the progress rate of various businesses and disrupted the global supply chains. The report further provides a future impact assessment of the Personalized Therapy Biosimulation Market concerning COVID-19.

Key players in the market include Cellworks Group Inc., Certara USA Inc., Simulation Plus Inc., Schrodinger Inc., In Silico Biosciences Inc., Genedata AG, Physiomics plc, Insilico Biotechology AG, Chemical Computing Group ULC (CCG), and Evidera Inc.

 Global Personalized Therapy Biosimulation Market Geographical Landscape - Synopsis:

  • The report closely studies the growth trajectory of the global Personalized Therapy Biosimulation Market . It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East Africa.
  • The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
  • Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.

Emergen Research has segmented the global personalized therapy biosimulation market on the basis of product, therapeutic area, application end-use, and region:

Product Outlook (Revenue, USD Billion; 2018–2028)

  • Software
  • Services

Therapeutic Area Outlook (Revenue, USD Billion; 2018–2028)

  • Oncology
  • Others

Application Outlook (Revenue, USD Billion; 2018–2028)

  • Drug Development
  • Drug Discovery
  • Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

  • Pharmaceutical Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others


 Report Highlights:


  • The report conducts a comparative assessment of the leading market players participating in the global Personalized Therapy Biosimulation Market .
  • The report marks the notable developments that have recently taken place in the Personalized Therapy Biosimulation Market tindustry
  • It details on the strategic initiatives undertaken by the market competitors for business expansion.
  • It closely examines the micro- and macro-economic growth indicators, as well as the essential elements of the Personalized Therapy Biosimulation Market value chain.
  • The repot further jots down the major growth prospects for the emerging market players in the leading regions of the market.


About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Find similar reports @

Topical Drug Delivery @

Joint Reconstruction @

Plant Genomics @

Electrotherapy Market @

Blood Pressure Monitoring Devices @

Contact Lenses @

Nanotechnology  @

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs